Dr. Aiswarya Sekar

Fertility-Preserving Cancer Care

Home / Fertility-Preserving Cancer Care

Fertility-Preserving Cancer Care – Protecting Your Future

A gynecologic cancer diagnosis brings many concerns, but for young women who have not completed their families, the fear of losing the ability to have children can be overwhelming. Fortunately, advances in gynecologic oncology now allow many women with early-stage cancers to preserve fertility while still achieving excellent cancer outcomes.

Dr. Aiswarya Sekar specializes in fertility-sparing cancer treatment, combining oncologic expertise with deep understanding of reproductive concerns to help young women navigate this challenging time.

Who May Be Candidates for Fertility Preservation?

Not every gynecologic cancer can be treated with fertility-sparing approaches, but carefully selected patients with early-stage disease may be eligible. Candidacy depends on:

  • Cancer type and subtype
  • Stage (extent of spread)
  • Grade (how abnormal cells appear)
  • Your age and reproductive goals
  • Willingness to accept close monitoring
  • Understanding that pregnancy should occur soon after treatment

Dr. Aiswarya carefully evaluates each situation, reviewing pathology, imaging, and individual circumstances to determine whether fertility-sparing treatment is oncologically appropriate.

Fertility-Sparing Options by Cancer Type

Ovarian Cancer

Unilateral Salpingo-Oophorectomy with Staging

For women with early-stage ovarian cancer confined to one ovary, surgery may remove:

  • The affected ovary and fallopian tube only
  • Leaving the uterus and other ovary intact
  • Complete surgical staging (lymph nodes, biopsies, omentum removal) to confirm cancer hasn’t spread


This approach is appropriate for:

  • Stage IA tumors (confined to one ovary)
  • Low-grade epithelial cancers
  • Most germ cell tumors
  • Many borderline ovarian tumors

Success Rates and Considerations:

  • Pregnancy rates of 60-70% after fertility-sparing surgery for early-stage ovarian cancer
  • Careful monitoring during and after pregnancy
  • Completion surgery (removing uterus and other ovary) recommended after childbearing complete


Dr. Aiswarya has extensive experience with fertility-sparing ovarian cancer surgery, performing meticulous staging while preserving reproductive organs.

Cervical Cancer

Cone Biopsy (Conization)

For the earliest stage cervical cancers (Stage IA1), removal of the affected portion of cervix through conization may be sufficient. This office or minor surgical procedure:

  • Removes a cone-shaped piece of cervix containing cancer
  • Leaves uterus and ovaries intact
  • Allows normal pregnancy and delivery


Candidates must have:

  • Very early, small tumors
  • No lymph node involvement
  • Favorable histology
  • Willingness for close follow-up


Radical Trachelectomy

For slightly larger early-stage cervical cancers (up to 2 cm), radical trachelectomy offers fertility preservation:

  • Removes cervix and upper vagina
  • Leaves uterus body intact
  • Includes pelvic lymph node assessment
  • Places permanent cerclage (stitch) at top of vagina


This complex procedure requires specialized expertise and careful patient selection. Success depends on tumor size and lymph node status.

Pregnancy After Trachelectomy:

  • Pregnancy possible in 40-70% of women attempting conception
  • Higher risk of preterm delivery due to shortened cervix
  • Close monitoring throughout pregnancy essential
  • Cesarean delivery required


Dr. Aiswarya provides comprehensive counseling about radical trachelectomy, discussing realistic expectations about pregnancy success and potential complications.

Endometrial Cancer

Hormonal Therapy

Young women with very early-stage, low-grade endometrial cancer (Grade 1 endometrioid adenocarcinoma without invasion) may be treated without surgery using:

High-Dose Progesterone Therapy

  • Oral or intrauterine device (IUD) delivering continuous progesterone
  • Regular endometrial biopsies to monitor response
  • Treatment duration typically 6-12 months
  • Pregnancy attempts encouraged once cancer resolves


Strict Criteria Required:

  • Grade 1 endometrioid adenocarcinoma only
  • No invasion into uterine muscle
  • No spread beyond uterus on imaging
  • Age typically under 40
  • Strong desire for pregnancy
  • Commitment to frequent monitoring
  • Understanding that cancer may recur


Success Rates:

  • 70-80% achieve complete response to hormonal therapy
  • 30-40% conceive after treatment
  • 25-40% experience cancer recurrence, especially after pregnancy
  • Most recurrences are still early-stage and curable


This approach requires intensive monitoring with repeat biopsies every 3 months and immediate pregnancy attempts once cancer resolves.

Dr. Aiswarya carefully counsels women considering fertility-sparing treatment for endometrial cancer, ensuring realistic understanding of success rates, monitoring requirements, and recurrence risks.

Borderline Ovarian Tumors

Borderline tumors (low malignant potential) have excellent prognosis and are highly suitable for fertility preservation:

  • Unilateral oophorectomy often sufficient
  • Completion staging may be performed at cesarean delivery after childbearing complete
  • Pregnancy does not increase recurrence risk
  • Long-term surveillance important even after completion surgery

Germ Cell Ovarian Tumors

These rare cancers primarily affect young women and are highly curable even at advanced stages:

  • Fertility-sparing surgery appropriate for almost all stages
  • Chemotherapy when needed does not usually cause permanent infertility
  • Excellent pregnancy rates after treatment completion

Additional Fertility Preservation Strategies

Ovarian Preservation During Hysterectomy

Women undergoing hysterectomy for cervical or endometrial cancer who do not need their uterus but wish to avoid premature menopause may preserve ovaries if oncologically safe. This maintains:

  • Hormonal function
  • Bone and cardiovascular health
  • Sexual function


Ovaries can be left in place or, for cervical cancer requiring radiation, moved surgically (ovarian transposition) out of radiation field to preserve function.

Egg or Embryo Freezing

Before chemotherapy or radiation therapy, which may damage ovarian function, fertility preservation options include:

Egg Freezing (Oocyte Cryopreservation)

  • Ovarian stimulation with hormone injections
  • Egg retrieval procedure
  • Freezing of mature eggs for future use
  • Requires 2-6 weeks before cancer treatment

Embryo Freezing

  • For women with male partners
  • Eggs fertilized before freezing
  • Slightly higher success rates than egg freezing alone

Ovarian Tissue Freezing

  • Experimental technique
  • Ovarian tissue removed and frozen
  • May be reimplanted after cancer treatment
  • Option when treatment cannot be delayed

Dr. Aiswarya coordinates with reproductive endocrinologists to arrange fertility preservation before cancer treatment begins whenever possible.

Ovarian Suppression During Chemotherapy

For some cancers, medications that temporarily shut down ovarian function during chemotherapy may help preserve fertility, though evidence is still emerging.

Timing of Pregnancy After Cancer Treatment

When fertility-sparing treatment is successful, pregnancy timing recommendations depend on cancer type:

Ovarian Cancer

  • Wait 6-12 months after surgery before attempting pregnancy
  • Complete any needed chemotherapy first
  • Close monitoring during pregnancy


Cervical Cancer

  • After trachelectomy: may attempt pregnancy once healing complete (3-6 months)
  • After chemotherapy: wait recommended period based on specific drugs used


Endometrial Cancer

  • Attempt pregnancy immediately once cancer resolves on biopsy
  • Delay increases recurrence risk
  • Progesterone therapy during pregnancy to protect against recurrence

Pregnancy Management After Fertility-Sparing Treatment

Pregnancy after gynecologic cancer treatment requires specialized obstetric care:

  • High-risk obstetrics monitoring
  • Frequent ultrasounds to assess cervical length (after trachelectomy)
  • Higher risk of preterm delivery
  • Cesarean delivery is often recommended, if you’ve underwent cervical cancer treatment before
  • Careful evaluation to ensure cancer hasn’t recurred

When Fertility Preservation Isn't Possible

Sometimes cancer characteristics make fertility-sparing treatment unsafe. In these situations:

  • Cancer cure must be the priority
  • Standard cancer surgery with removal of reproductive organs is necessary
  • Egg/embryo freezing may still preserve genetic parenthood possibility through gestational carrier
  • Adoption and other family-building options remain available


Dr. Aiswarya provides compassionate counseling when fertility preservation isn’t possible, acknowledging grief while maintaining focus on life-saving treatment.

Psychological Support

Facing cancer while concerned about future fertility creates unique emotional challenges. Dr. Aiswarya recognizes these concerns and provides:

  • Time to discuss fertility goals before finalizing treatment plans
  • Realistic expectations about success rates
  • Coordination with fertility specialists
  • Connection to counseling resources
  • Support throughout decision-making process

Shared Decision-Making

Choosing fertility-sparing treatment involves balancing cancer cure with reproductive goals. Dr. Aiswarya believes in shared decision-making:

  • Providing complete information about oncologic outcomes with standard vs. fertility-sparing approaches
  • Discussing realistic pregnancy success rates
  • Explaining monitoring requirements and potential complications
  • Supporting your decision once made
  • Ensuring you feel comfortable with the plan

Long-Term Outcomes

Research demonstrates that for appropriately selected patients, fertility-sparing surgery achieves excellent cancer outcomes comparable to standard treatment, while allowing:

  • Successful pregnancies in majority of women who attempt conception
  • Normal healthy children
  • Completion surgery after childbearing to reduce future cancer risk

Multidisciplinary Collaboration

Optimal fertility-preserving cancer care requires collaboration among:

  • Gynecologic oncologists
  • Reproductive endocrinologists
  • High-risk obstetricians
  • Genetic counselors (for hereditary cancers)
  • Mental health professionals


Dr. Aiswarya coordinates all aspects of care, ensuring seamless communication among specialists throughout your journey.

Your Partner in This Journey

Facing cancer while hoping to preserve fertility requires specialized expertise, compassionate counseling, and individualized decision-making. Dr. Aiswarya combines oncologic excellence with deep understanding of reproductive concerns, supporting young women through this challenging time.

If you’ve been diagnosed with gynecologic cancer and have concerns about fertility, specialized consultation can help you understand your options. Contact us today to schedule an appointment.